Breast Cancer Profiling Project, Drug Sensitivity phase I: Fixed-cell GR measures of 35 breast cell lines to 34 small molecule perturbagens from library plate I. Dataset 2 of 2: Calculated dose response metrics - Dataset (ID:20344)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Primary Target | Pathway | GR50 | GRmax | GR_AOC | Death_AUC | GR Hill Coefficient | GEC50 | GR r2 |
---|---|---|---|---|---|---|---|---|---|---|
SK-BR-3 | Abemaciclib | CDK4/6 | Cell cycle | 0.035311 | 0.1432 | 0.5363 | 0.0387 | 0.6381 | 0.016543 | 0.96857 |
MCF7 | AZD7762 | CHK1/2 | Cell cycle | 0.04144 | -0.1856 | 0.5977 | 0.1318 | 0.8993 | 0.048851 | 0.95892 |
MCF7 | Palbociclib | CDK4/6 | Cell cycle | 0.074952 | 0.2542 | 0.3461 | 0.0139 | 1.0473 | 0.035667 | 0.99237 |
MCF7 | Abemaciclib | CDK4/6 | Cell cycle | 0.023572 | -0.2684 | 0.7018 | 0.0913 | 0.3795 | 0.13917 | 0.95433 |
HCC1806 | Abemaciclib | CDK4/6 | Cell cycle | 0.59453 | -0.4440 | 0.3921 | 0.1035 | 0.6190 | 3.5069 | 0.96621 |
MCF7 | Dinaciclib | pan CDK | Cell cycle | 0.0083068 | -0.2493 | 0.6441 | 0.1256 | 3.5461 | 0.009348 | 0.9995 |
MDA-MB-134-VI | Volasertib | PLK | Cell cycle | 0.0027209 | -0.6274 | 1.0260 | 0.2671 | 5.0000 | 0.0032225 | 0.99553 |
MDA-MB-134-VI | Dinaciclib | pan CDK | Cell cycle | 0.010529 | -0.8440 | 0.7452 | 0.1522 | 2.1701 | 0.015963 | 0.99365 |
MDA-MB-231 | Volasertib | PLK | Cell cycle | 0.0043583 | -0.0186 | 0.5873 | 0.1359 | 3.6103 | 0.0044117 | 0.99795 |
BT-549 | Abemaciclib | CDK4/6 | Cell cycle | 3.9707 | 0.0333 | 0.1267 | 0.0188 | 1.2825 | 7.5655 | 0.99654 |
SK-BR-3 | Dinaciclib | pan CDK | Cell cycle | 0.0068129 | -0.6209 | 0.8362 | 0.3009 | 3.4320 | 0.008573 | 0.99807 |
MDA-MB-157 | Volasertib | PLK | Cell cycle | 0.0069232 | -0.6644 | 0.8547 | 0.2325 | 4.1331 | 0.0084606 | 0.99754 |
HCC1806 | Volasertib | PLK | Cell cycle | 0.0027998 | -0.1323 | 0.7262 | 0.2950 | 5.0000 | 0.0029495 | 0.99776 |
Hs 578T | Volasertib | PLK | Cell cycle | 0.0025675 | -0.3123 | 0.8198 | 0.3337 | 3.0081 | 0.0029864 | 0.9987 |
BT-20 | AZD7762 | CHK1/2 | Cell cycle | 1.081 | -0.5785 | 0.2831 | 0.1722 | 1.5948 | 1.8464 | 0.99406 |
BT-549 | Volasertib | PLK | Cell cycle | 0.0088352 | -0.2289 | 0.5676 | 0.1490 | 2.4967 | 0.0098732 | 0.99586 |
MDA-MB-231 | Dinaciclib | pan CDK | Cell cycle | 0.010273 | -0.4203 | 0.6627 | 0.2555 | 2.6877 | 0.012709 | 0.99722 |
MCF 10A | Abemaciclib | CDK4/6 | Cell cycle | 0.34027 | 0.1513 | 0.3811 | -0.0012 | 0.5714 | 0.28176 | 0.99756 |
MCF 10A | Palbociclib | CDK4/6 | Cell cycle | 1.9503 | 0.4544 | 0.1883 | -0.0047 | 0.6492 | 0.23713 | 0.99244 |
MCF 10A | AZD7762 | CHK1/2 | Cell cycle | 1.8064 | -0.1800 | 0.2246 | 0.0802 | 0.8472 | 6.6065 | 0.99793 |
MCF 10A | Volasertib | PLK | Cell cycle | 0.022128 | -0.0887 | 0.4466 | 0.1711 | 3.5358 | 0.023168 | 0.99997 |
MCF 10A | Dinaciclib | pan CDK | Cell cycle | 0.016244 | -0.2300 | 0.5279 | 0.2344 | 5.0000 | 0.017523 | 0.99904 |
Hs 578T | AZD7762 | CHK1/2 | Cell cycle | 0.015096 | -0.5983 | 0.8646 | 0.4133 | 1.8783 | 0.01967 | 0.95944 |
MDA-MB-361 | Dinaciclib | pan CDK | Cell cycle | 0.011817 | -0.2748 | 0.6004 | 0.0836 | 5.0000 | 0.013067 | 0.99187 |
MDA-MB-361 | Volasertib | PLK | Cell cycle | 0.0035439 | -0.4972 | 0.8204 | 0.1921 | 4.6311 | 0.0040451 | 0.98886 |